Atricure Inc. Stock
Atricure Inc. Stock
With 13 Buy predictions and not the single Sell prediction the community is currently very high on Atricure Inc..
However, we have a potential of -29.41% for Atricure Inc. as the target price of 42 € is below the current price of 59.5 €.
Pros and Cons of Atricure Inc. in the next few years
Pros
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Atricure Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Atricure Inc. | - | - | - | - | - | - | - |
Orasure Tech | -0.980% | 2.642% | -8.182% | -18.548% | -32.215% | -32.306% | -41.827% |
scPharmaceuticals | -3.170% | 0.943% | -6.550% | -58.039% | -25.565% | -11.203% | - |
SI-BONE Inc | -3.700% | -2.985% | -7.143% | -39.815% | -31.579% | -51.128% | - |
Comments
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at JPMorgan Chase & Co. from $42.00 to $34.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at Needham & Company LLC from $46.00 to $40.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
AtriCure, Inc. (NASDAQ: ATRC) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $32.00 price target on the stock.
Show more
Ratings data for ATRC provided by MarketBeat